Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity

OBJECTIVE: This study was conducted to determine whether increased body mass index (BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of hypothalamic-pituitary-ovarian (HPO) axis activity. STUDY DESIGN: Ovulatory reproductive-age women of normal (< 25 kg/m(2); n = 10) and obes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Edelman, Alison B, Carlson, Nichole E, Cherala, Ganesh, Munar, Myrna Y., Stouffer, Richard L, Cameron, Judy L, Stanczyk, Frank Z., Jensen, Jeffrey T
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2736633/
https://ncbi.nlm.nih.gov/pubmed/19631786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2009.04.011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares